Technology
Health
Pharmaceutical

BiondVax Pharmaceuticals

$5.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.20 (-3.33%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell BVXV and other stocks, options, ETFs, and crypto commission-free!

About BVXV

BiondVax Pharmaceuticals Ltd. American Depositary Shares, also called BiondVax Pharmaceuticals, is a clinical stage biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infectious diseases. Read More It works on M-001, a synthetic peptide-based protein targeting both seasonal and pandemic strains of the influenza virus. The company was founded by Ron Babecoff and Rami Epstein on July 22, 2003 and is headquartered in Jerusalem, Israel.

Employees
21
Headquarters
Jerusalem, Jerusalem
Founded
2003
Market Cap
39.21M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
8.98K
High Today
$5.95
Low Today
$5.80
Open Price
$5.93
Volume
4.80K
52 Week High
$7.26
52 Week Low
$3.51

Collections

Technology
Health
Pharmaceutical
Medical
Biopharmaceutical
2015 IPO
Asia (Non-China)
Asia

BVXV Earnings

-$0.05
-$0.03
-$0.02
$0.00
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 27, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.